No. 19-1451
 
Title: Sanofi-Aventis Deutschland GmbH, Petitioner
v.
Mylan Pharmaceuticals Inc.
Docketed: July 2, 2020
Lower Ct: United States Court of Appeals for the Federal Circuit
   Case Numbers: (2019-1368, 2019-1369)
   Decision Date: November 19, 2019
   Rehearing Denied: January 28, 2020
 
Proceedings and Orders
Jun 26 2020 Petition for a writ of certiorari filed. (Response due August 3, 2020)
Petition Certificate of Word Count Proof of Service
Jul 28 2020 Motion to extend the time to file a response from August 3, 2020 to August 24, 2020, submitted to The Clerk.
Main Document Proof of Service
Jul 29 2020 Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2020.
Aug 24 2020 Brief of respondent Mylan Pharmaceuticals Inc. in opposition filed.
Main Document Certificate of Word Count Proof of Service
Sep 08 2020 Reply of petitioner Sanofi-Aventis Deutschland GmbH filed. (Distributed)
Main Document Proof of Service Certificate of Word Count
Sep 09 2020 DISTRIBUTED for Conference of 9/29/2020.
Oct 05 2020 Petition DENIED.
Attorneys
Attorneys for Petitioners
Adam Baker Banks
Counsel of Record
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, NY 10153

adam.banks@weil.com
Ph: 212 310-8000
Party name: Sanofi-Aventis Deutschland GmbH


Attorneys for Respondents
Douglas H Carsten
Counsel of Record
Wilson Sonsini Goodrich & Rosati
12235 El Camino Real
San Diego, CA 92130

dcarsten@wsgr.com
Ph: 8583502305
Party name: Mylan


Steffen Nathanael Johnson
Counsel of Record
Wilson Sonsini Goodrich & Rosati
1700 K Street, NW, Fifth Floor
Washington, DC 20006

sjohnson@wsgr.com
Ph: (202) 973-8888
Party name: Mylan Pharmaceuticals Inc.


Richard Lee Torczon Jr.
Wilson Sonsini Goodrich and Rosati PC
1700 K Street, NW
Floor 5
Washington, DC 20006-3817

rtorczon@wsgr.com
Ph: 202-973-8811
Party name: Mylan Pharmaceuticals Inc.